August 27, 2016

Genomic Profiling of Breast Cancer in African-American Women Using MammaPrint.

PUBLICATION: 
Breast Cancer Res Treat (2016) 159: 481. https://doi.org/10.1007/s10549-016-3949-y09.

AUTHORS: 
Raquel A. Nunes, Lynette Wray, Mihriye Mete, Pia Herbolsheimer, Karen L. Smith, Lana Bijelic, Marc E. Boisvert, Sandra M. Swain

SUMMARY: 
We evaluated gene expression in tumors from AAF presenting with early stage or locally advanced breast cancer using MammaPrint, BluePrint (molecular subtype) and TargetPrint, correlated with OncotypeDX and clin-path. High Risk MammaPrint was present in 66% of patients and in 52% of patients with stage I disease.

Read more: Nunes et al_2016_Breast Cancer Research and Treatment_Genomic profiling of breast cancer in African-American women using MammaPrint